News

Search:

Report: Track and Trace Negotiations Resume in Congress

0 Likes

Track-and-trace is dead; long live track-and-trace.Politico reports staff members associated with the House Energy and Commerce (E&C) Subcommittee on Health and the Senate Health, Education, Labor and Read More...

Tags:

Congress

FDASIA

Legislation

Serialization

Track and Trace

User Fee Bills

Report: Track and Trace Provisions Removed from User Fee Bill

0 Likes

Provisions aimed at establishing a system in which drug products would be given unique identifying numbers—a so-called ‘track and trace’ system—has been removed from a draft user fee bill intended to Read More...

Tags:

Congress

Legislation

PDUFA

Serialization

Track and Trace

User Fee Bills

Legislators: To Help Alleviate Drug Shortages, Establish Track and Trace Provisions

0 Likes

Two Democratic legislators this week sent a letter to members of the Senate’s and House of Representatives’ healthcare oversight committees detailing the findings of the legislators’ investigation Read More...

Tags:

Congress

Cummings

Drug Shortages

Gray Market

Investigation

Legislation

PDUFA

Rockefeller

Serialization

Track and Trace

User Fee Bills

RF Today is Regulatory Focus' daily news brief. Each edition contains the top global regulatory news stories about pharmaceuticals, medical devices, biotechnology and more. Learn more

Most Viewed
Most Popular

Most Viewed

China's SFDA Becomes CFDA amidst Consolidation of Power and New Leadership 25 March 2013
FDA Plans Huge Cardiovascular Registry With Focus on Medical Devices 2 April 2013
In Unprecedented Shift, EU Parliament Proposes Premarket Authorization for Medical Devices 15 April 2013
Goodbye, KFDA: Korean Regulator Gets New Name, Decentralized Authority After Reorganization 28 March 2013
FDA Gets Go-Ahead for Study of DTC Advertising and Social Media 18 April 2013
UPDATED: President's Budget Proposal Calls for Small Increases at FDA, but Big Changes for Industry 11 April 2013
IBM Awarded Huge Contract to Modernize Regulatory Review Processes at FDA 29 April 2013
New FDA Document Clarifies IND Process for Drugs, Biologics and Biosimilars 30 April 2013

New Regulatory Focus Apps for iPad and iPhone

Stay Connected:

Regulatory Focus is for regulatory professionals written by regulatory professionals.

The publication takes a look at the important topics facing regulatory professionals in a changing global healthcare landscape. From topics ranging from research and development to labeling and marketing, the articles try to analyze, inform, and educate readers about the issues at the forefront of the industry.

Rated as the number one benefit by the members of RAPS, Regulatory Focus strives to provide the best and most current information to regulatory professionals so they can succeed and advance at every stage in their careers.

For questions or comments on our content or to find out more about Regulatory Focus, please visit our About RF page.

News

Report: Track and Trace Negotiations Resume in Congress

Report: Track and Trace Provisions Removed from User Fee Bill

Legislators: To Help Alleviate Drug Shortages, Establish Track and Trace Provisions

Get RF Today